Dangers of older allergy drugs often underestimated
GA²LEN position paper on the risk of first-generation H1-antihistamines is available online
GA²LEN experts warn that older antihistamines in over-the-counter allergy medications – the most common form of self-medication in allergic rhinitis – may be hazardous to our health. The report published in Allergy on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. Read the abstract online
Register to GA²LEN Annual Conference 2010
New topics in Bradykinin GA²LEN 2010 Annual Conference and Assembly will be held in Berlin, Germany, on 25-26 March 2010. Check the conference website for more information on the programme, abstract submission and registration. More information - Register now
GA²LEN Achievements published in Allergy journal
GA²LEN addresses the allergy and asthma 'epidemic' Created in 2005, GA²LEN (Global Allergy and Asthma European Network) brings together research and clinical centres to combat fragmentation in the European research area and to tackle Allergy in its globality. Major GA²LEN achievements to date are reported in the publication: (i) related to the development of a durable infrastructure, (ii) project-related research results, and (iii) related to the drafting and implementation of guidelines. Online abstract More information on GA²LEN Research
